GlassScriptPhysician profile
Tobias Walbert
NPI 1952511933
$56,396.15
in general payments reported to CMS, 2019-2025
11 companies · $22K in 2025
The $22K reported for 2025 was more than what 93% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,117 · 2020: $505 · 2021: $5,942 · 2022: $9,314 · 2023: $3,000 · 2024: $10K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,508 · Travel and Lodging: $1,816 · Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,680.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,507.50 |
| Travel and Lodging | $1,815.51 |
| Food and Beverage | $514.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $19,500.00 | 2019-2023 | |
| Springworks Therapeutics, INC. | $18,789.74 | 2024-2025 | Gomekli |
| Alexion Pharmaceuticals, INC. | $15,677.79 | 2022-2025 | Koselugo |
| Astrazeneca Pharmaceuticals LP | $2,133.34 | 2019-2021 | |
| Servier Pharmaceuticals LLC | $231.30 | 2021 | |
| Merck Sharp & Dohme LLC | $63.98 | 2022 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tobias Walbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.